Who owns Glycomimetics?
- Ticker: GLYC
- CUSIP Number: 38000q102
Tip: Access positions for across all investors
Analyze quarterly positions in Glycomimetics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Glycomimetics stock
Who bought or sold Glycomimetics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 9.5M | $23M | 0% | Dec 2023 |
|
| Artal Group | 8.6M | $20M | 0% | Dec 2023 |
|
| NEA Management Company | 4.8M | $11M | 0% | Dec 2023 |
|
| Octagon Capital Advisors | 3.0M | $7.1M | 0% | Dec 2023 |
|
| Vanguard Group | 2.4M | $5.7M | 0% | Dec 2023 |
|
| Goldman Sachs Group | 919k | $2.2M | 16% | Dec 2023 |
|
| GSA Capital Partners | 201k | $474k | 114% | Dec 2023 |
|
| Two Sigma Advisers | 165k | $390k | -24% | Dec 2023 |
|
| Connor, Clark & Lunn Investment Management | 143k | $338k | -4% | Dec 2023 |
|
| Advisor OS | 101k | $238k | 100% | Dec 2023 |
|
| Franklin Resources | 96k | $226k | 0% | Dec 2023 |
|
| Simplex Trading | 72k | $170k | 100% | Dec 2023 |
|
| Two Sigma Investments | 60k | $141k | -48% | Dec 2023 |
|
| Sargent Investment Group | 58k | $137k | 0% | Dec 2023 |
|
| Jane Street | 57k | $135k | 186% | Dec 2023 |
|
| Intellectus Partners | 51k | $120k | -18% | Dec 2023 |
|
| Letko, Brosseau & Associates | 45k | $107k | 0% | Dec 2023 |
|
| Millennium Management | 39k | $92k | -39% | Dec 2023 |
|
| Ieq Capital | 38k | $91k | 0% | Dec 2023 |
|
| Virtu Financial | 34k | $81k | 100% | Dec 2023 |
|
| Bank of New York Mellon | 25k | $58k | -1% | Dec 2023 |
|
| Citadel Advisors | 24k | $58k | 100% | Dec 2023 |
|
| Charles Schwab Investment Management | 22k | $53k | 0% | Dec 2023 |
|
| Citigroup | 22k | $51k | 100% | Dec 2023 |
|
| Bank of America Corporation | 20k | $47k | 143% | Dec 2023 |
|
| 683 Capital Management | 19k | $46k | 100% | Dec 2023 |
|
| Marshall Wace | 13k | $30k | 100% | Dec 2023 |
|
| Pine Valley Investments Ltd Liability | 13k | $30k | 0% | Dec 2023 |
|
| Hartford Financial Management | 3.5k | $8.3k | 0% | Dec 2023 |
|
| Jpmorgan Chase & Co | 1.6k | $3.8k | 246% | Dec 2023 |
|
| Rhumbline Advisers | 1.0k | $2.5k | 0% | Dec 2023 |
|
| UBS Group | 683.00 | $1.6k | 100% | Dec 2023 |
|
| ORG Partners | 500.00 | $1.2k | 100% | Dec 2023 |
|
| Bnp Paribas Arbitrage, Snc | 481.00 | $1.1k | 0% | Dec 2023 |
|
| Wells Fargo & Company | 377.00 | $889.983900 | 6% | Dec 2023 |
|
| Barclays | 76.00 | $0 | -50% | Dec 2023 |
|
Who sold out of Glycomimetics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Mjp Associates | Dec 2023 | 101k | $238k |
| Dimensional Fund Advisors | Sep 2023 | 45k | $67k |
| Chicago Partners Investment | Sep 2023 | 20k | $23k |
| Commonwealth Equity Services | Sep 2023 | 10k | $15k |
| Creative Planning | Sep 2023 | 10k | $15k |
| Signature | Sep 2023 | 100.00 | $150.000000 |